Skip to main content
Premium Trial:

Request an Annual Quote

PrimeraDx Reels in $20M in Investments

NEW YORK (GenomeWeb News) – The molecular diagnostics firm PrimeraDx has closed $20 million in a Series C financing round through investments from new and existing investors.

This round of investments was led by CHL Medical Partners and included Abingworth, InterWest Partners, Malaysian Technology Development, MPM Capital, Burrill & Company, and the Invus Group.

PrimeraDx CEO and President Martin Verhoef said in a statement that the company will use the funding to continue commercializing its technology, including advancing its regulatory strategy and broadening a quantitative, multiplexed assay menu to run on its ICEPlex system.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.